相关实验视频

Updated: May 15, 2025

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

PLGA-hucMSC-Ex通过逆转上皮质-介质细胞过渡来改善结肠炎

Ziyue Liu¹, Jintao Yuan², Lan Wang³

¹Department of Laboratory Medicine, Affiliated People's Hospital, Jiangsu University, Zhenjiang, 212002, Jiangsu, P.R. China.

Current stem cell research & therapy

|April 10, 2025

概括

外体载荷微粒的口服有效治疗小鼠的炎症性肠病 (IBD). 这种新的输送方法保护治疗外体,为IBD患者提供了传统静脉注射的有希望的替代方案.

科学领域:

生物医学工程生物医学工程
再生医学是一种再生医学.
胃肠病学胃肠病学

背景情况:

人类带介质干细胞衍生的外体细胞 (hucMSC-Exs) 对炎症性肠病 (IBD) 显示出治疗潜力.
目前的输送方法,如尾静脉注射,由于胃肠道的恶劣环境,面临着挑战.
外体是有价值的生物药物或生物活性物质的载体.

研究的目的:

开发一种口服可输送的外体细胞配方,用于IBD治疗.
为了提高hucMSC-Exs在胃肠道中的稳定性和有效性.
在IBD模型上研究PLGA-hucMSC-Ex颗粒的治疗效果.

主要方法:

hucMSC-Exs被封装在聚 (乳酸-co-甘油酸) (PLGA) 中,使用双乳液法创建PLGA-hucMSC-Ex微粒.
在IBD小鼠模型中评估了PLGA-hucMSC-Ex颗粒口服的疗效.

主要成果:

在IBD小鼠模型中,口服PLGA-hucMSC-Ex颗粒可显著缓解IBD小鼠模型中的炎症.
治疗效果归因于逆转IBD诱导的上皮层-介质细胞过渡 (EMT).

结论:

PLGA-hucMSC-Ex微粒为IBD治疗提供了一个可行的口服输送策略.
这种方法为患者的IBD管理提供了潜在的临床应用.
这项研究为胃肠道疾病提供了替代常规外体输送方法的替代方案.

关键词:

在EMT中,EMT是EMT.这就是HucMSC-Ex.IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD 在 PLGA PLGA 中.通过口服进行口服管理.治疗. 治疗. 治疗.

更多相关视频

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance

Published on: December 3, 2020

相关概念视频

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

Renewal of Intestinal Stem Cells

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...